XTL Biopharmaceuticals Ltd reported that the letter of intent for acquiring NeuroNOS Ltd with Beyond Air, Inc. expired on March 9, 2026, as no definitive agreement was reached. This event is significant as it confirms the termination of negotiations regarding the proposed acquisition.